The potassium test measures the amount of potassium in the blood. Almost all of the body's potassium sits inside cells, so a small change in the blood level changes how nerves, muscles and the heart conduct. It is part of the basic metabolic panel and is ordered to monitor kidney disease, heart disease, diuretics and other drugs that shift potassium, and clients with weakness or an irregular heartbeat.
Checked against the sources below November 2026
Normal range
Test
US units
SI units
Notes
Potassium
3.5–5.0 mEq/L
3.5–5.0 mmol/L
Adult ranges. Ranges differ a little between laboratories; use the range printed on your lab’s report. All chemistry values
Potassium in the ICU
In DKA the first potassium is often normal or high even though the body is depleted, because acidosis pushes potassium out of cells. Merck advises withholding insulin until potassium is at least 3.3 mEq/L and checking it every 1 to 2 hours early in treatment.
Urgent IV replacement for dysrhythmias or a very low level, up to 40 mEq per hour, is used only with continuous cardiac monitoring, a central line or more than one peripheral line, and hourly potassium levels, per facility policy.
Calcium works within minutes but lasts only 20 to 30 minutes, and insulin peaks at about 1 hour. Expect potassium to drift back up, so time rechecks and repeat ECGs to the treatment, and expect a dextrose infusion after the insulin to prevent late hypoglycemia.
Transfusion shifts potassium both ways. Blood stored more than a week can raise potassium in a client with kidney failure, while red cells stored more than 3 weeks can lower it about 24 hours later.
Sodium bicarbonate given for acidosis can worsen hypokalemia, so watch the potassium closely after it.
Hyperkalemia
Peaked T waves often appear above 5.5 mEq/L. Above 6.5 mEq/L the QRS widens and P waves are lost, and the rhythm can decline to ventricular fibrillation or asystole.
Causes
Acute kidney injury or chronic kidney disease
ACE inhibitors, ARBs, potassium-sparing diuretics, NSAIDs or trimethoprim
Potassium supplements, IV potassium or transfusion of stored blood
Metabolic acidosis and insulin deficiency, as in DKA
Cell breakdown from burns, crush injury, rhabdomyolysis or tumor lysis
Adrenal insufficiency or low aldosterone
A hemolyzed sample, which raises the result falsely
Signs and symptoms
Often no symptoms until a dysrhythmia appears
Tall, narrow, peaked T waves
Prolonged PR interval, then a wide QRS and loss of P waves
Muscle weakness or flaccid paralysis
Nausea and numbness or tingling
Sine-wave rhythm, ventricular fibrillation or asystole
Nursing actions
Place the client on a cardiac monitor and get a 12-lead ECG.
Report the result and any ECG change to the provider at once.
Report a possibly hemolyzed sample and anticipate a repeat draw, but never wait for it when the ECG shows changes.
Hold potassium supplements and potassium in IV fluids until the provider reviews them.
Anticipate IV calcium gluconate to protect the heart when the ECG shows changes, given with caution if the client takes digoxin.
Anticipate insulin with dextrose to shift potassium into cells, and check glucose for hypoglycemia afterward.
Anticipate a binder, a loop diuretic or hemodialysis to remove potassium from the body.
Recheck the potassium level after each treatment as ordered.
Hypokalemia
Levels of 3.0 to 3.4 mEq/L often cause no symptoms. Weakness appears from about 2.5 to 3.0 mEq/L, and cardiac effects usually start below 3 mEq/L.
Causes
Loop and thiazide diuretics, the most common cause
Vomiting or gastric suction
Diarrhea or laxative overuse
Insulin, beta-2 agonists such as albuterol, or refeeding
Low magnesium, which makes the kidneys waste potassium
Excess aldosterone or cortisol, as in Cushing syndrome
Amphotericin B or some high-dose penicillins
Signs and symptoms
Muscle weakness, cramps or twitching
Constipation or paralytic ileus
Flat or inverted T waves, ST depression and a U wave
PVCs, tachydysrhythmias or heart block
Shallow breathing or respiratory failure when severe
Polyuria and thirst
Nursing actions
Place the client on a cardiac monitor when the level is moderate or severe, or the client takes digoxin.
Assess muscle strength, breathing effort and bowel sounds.
Give oral potassium as ordered, since it is first line when the client can take it.
Never give potassium by IV push; the label warns that undiluted injection can be instantly fatal.
Run IV potassium diluted on an infusion pump at the ordered rate, per facility policy.
Check the IV site often, since concentrated potassium irritates veins.
Anticipate a magnesium level and magnesium replacement, since potassium will not correct while magnesium stays low.
Teach clients on diuretics to keep their lab appointments and report weakness or palpitations.
Drawing and reading the sample
Hemolysis of the sample raises potassium falsely
A long tourniquet time or repeated fist clenching during the draw can raise the result
Very high platelet or white cell counts can raise a serum result falsely
Natural black licorice can lower potassium; MedlinePlus advises avoiding it for two weeks before the test
On the exam
The potassium chloride label limits a routine infusion to 10 mEq per hour at no more than 40 mEq per liter; follow facility policy.
Digoxin plus low potassium raises the risk of digoxin-related dysrhythmias even when the low is mild.
Peaked T waves mean high potassium; a U wave and flat T waves mean low potassium.
Calcium gluconate protects the heart but does not lower the potassium level.
Check yourself: 4 questions
Question 1 · Advanced ICU Pharmacology
A patient with K⁺ 7.5 and a widened QRS has just received IV calcium gluconate 3 g, and the QRS has narrowed. Which intervention should follow NEXT to lower the serum potassium quickly?
Oral sodium polystyrene sulfonate alone
IV furosemide 40 mg in an anuric patient
IV insulin with dextrose, plus nebulized albuterol
More calcium every 5 minutes as the only therapy
Show the answer and rationale
Answer: C
A. Binders act over hours and do not shift potassium quickly.
B. Loop diuretics are ineffective without urine output.
C.Correct. Insulin and β₂ agonists shift potassium into cells within minutes, bridging to definitive removal.
D. Calcium stabilizes the membrane but does not lower potassium.
Hyperkalemia with ECG changes is treated in phases: stabilize the membrane (IV calcium), shift potassium into cells (regular insulin 5–10 units IV with dextrose, nebulized albuterol 10–20 mg, and bicarbonate if acidotic), and remove it (dialysis, potassium binders, diuretics if the kidneys work). The nurse monitors glucose for several hours after insulin, especially in renal failure, and repeats potassium checks because rebound is common.
A patient resuscitated from cardiac arrest has K⁺ 2.9 mEq/L one hour after ROSC without GI or renal losses. What BEST explains the hypokalemia?
Aldosterone surge causing renal potassium loss
Dilution from rapid expansion of extracellular fluid
Catecholamine β₂ activation of Na⁺/K⁺-ATPase
Glomerular injury leaking potassium into urine
Show the answer and rationale
Answer: C
A. Aldosterone acts over hours to days. It does not explain an acute shift within an hour.
B. Dilution causes only a minor effect.
C.Correct. Endogenous and given epinephrine stimulate β₂ receptors on skeletal muscle, shifting potassium into cells.
D. This is not a mechanism of acute hypokalemia.
β₂ stimulation activates Na⁺/K⁺-ATPase in skeletal muscle, rapidly moving potassium into cells. The effect is used therapeutically (albuterol for hyperkalemia) and is seen after cardiac arrest, MI, trauma, or with β-agonist infusions. Insulin and alkalosis have similar effects. Hypokalemia after ROSC increases arrhythmia risk, so potassium and magnesium are monitored closely and replaced cautiously, because potassium may rebound as catecholamine levels fall.
During rapid transfusion of multiple older PRBC units, a patient develops peaked T waves, and the potassium is 6.8 mEq/L. Which transfusion-related factor MOST likely contributed?
Citrate-induced hypocalcemia raising serum K⁺
Dilution by the saline additive solution
Potassium leaking from stored RBCs into the unit
Metabolic alkalosis from citrate metabolism
Show the answer and rationale
Answer: C
A. Hypocalcemia increases the cardiac effects of hyperkalemia but does not raise the potassium level.
B. Dilution would lower, not raise, the potassium.
C.Correct. The sodium-potassium pump slows during cold storage, and aging RBCs leak potassium into the supernatant.
D. Citrate is metabolized to bicarbonate, and the resulting alkalosis shifts potassium into cells, so it tends to lower, not raise, the serum level.
Stored RBCs leak potassium over time, and older and irradiated units have higher supernatant potassium. Rapid, large-volume transfusion, especially through central lines, in patients with acidosis, hypothermia, AKI, or low cardiac output can cause dangerous hyperkalemia and arrhythmias. Management includes IV calcium, insulin with dextrose, and correction of acidosis, and fresher or washed units can be requested for high-risk patients.
A patient on CVVHD (continuous venovenous hemodialysis) has a potassium of 6.9 mEq/L that falls steadily over several hours. Which mechanism is PRIMARILY responsible for the potassium removal?
Adsorption of potassium onto the filter surface
Active transport through membrane ATP pumps
Convection, with solute dragged along in ultrafiltrate
Diffusion down a concentration gradient
Show the answer and rationale
Answer: D
A. Some membranes adsorb proteins, but potassium is removed mainly by diffusion.
B. Dialysis membranes are passive and have no active transport.
C. Convection dominates in hemofiltration (CVVH), which uses replacement fluid rather than dialysate.
D.Correct. In CVVHD, potassium moves from blood into low-potassium dialysate across the membrane.
Diffusion moves solutes from higher to lower concentration across the membrane and is most efficient for small molecules such as potassium, urea, and creatinine. It is driven by dialysate flow in hemodialysis modes. Convection (solvent drag) removes solutes along with ultrafiltered plasma water, is driven by transmembrane pressure, and is more effective for middle molecules. CVVHDF combines both mechanisms.
Reference range: MedlinePlus Medical Encyclopedia ranges (National Library of Medicine, reviewed 2024–2026); ABIM laboratory reference ranges (January 2026) for hemoglobin, hematocrit and potassium; Merck Manual for ionized calcium; the heparin label for the aPTT target; ASHP/IDSA 2020 vancomycin guideline
For education and exam preparation only. Reference ranges and critical values vary by laboratory. Follow your facility’s policy and the prescriber’s orders.